Bicocca Open Archive

Logo unimib boa
CADAMURO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.487
AS - Asia 8.740
EU - Europa 5.792
SA - Sud America 1.209
Continente sconosciuto - Info sul continente non disponibili 619
AF - Africa 210
OC - Oceania 21
Totale 30.078
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.783
SG - Singapore 2.705
CN - Cina 1.870
IT - Italia 1.803
VN - Vietnam 1.487
HK - Hong Kong 1.058
RU - Federazione Russa 974
BR - Brasile 898
SE - Svezia 599
DE - Germania 561
CA - Canada 530
IE - Irlanda 451
BD - Bangladesh 340
GB - Regno Unito 297
UA - Ucraina 283
IN - India 247
KR - Corea 227
FR - Francia 223
FI - Finlandia 198
ID - Indonesia 146
AR - Argentina 120
IQ - Iraq 102
TR - Turchia 102
JP - Giappone 86
ES - Italia 77
MX - Messico 77
ZA - Sudafrica 72
PK - Pakistan 71
NL - Olanda 69
EC - Ecuador 53
AT - Austria 52
CO - Colombia 46
PL - Polonia 46
SA - Arabia Saudita 37
UZ - Uzbekistan 37
VE - Venezuela 31
DK - Danimarca 30
TW - Taiwan 28
MA - Marocco 27
PH - Filippine 27
BE - Belgio 22
EG - Egitto 20
MY - Malesia 20
CL - Cile 18
KE - Kenya 18
CH - Svizzera 17
CR - Costa Rica 17
JO - Giordania 17
PY - Paraguay 17
TH - Thailandia 17
TN - Tunisia 16
AU - Australia 15
JM - Giamaica 15
TT - Trinidad e Tobago 15
HN - Honduras 14
CZ - Repubblica Ceca 13
IL - Israele 13
LT - Lituania 13
NP - Nepal 13
DZ - Algeria 12
ET - Etiopia 12
EU - Europa 12
AE - Emirati Arabi Uniti 11
NO - Norvegia 11
IR - Iran 10
LB - Libano 10
PE - Perù 9
PS - Palestinian Territory 9
RO - Romania 9
UY - Uruguay 9
AL - Albania 8
GT - Guatemala 8
BO - Bolivia 7
AZ - Azerbaigian 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
KZ - Kazakistan 6
NI - Nicaragua 6
RS - Serbia 6
SN - Senegal 6
BY - Bielorussia 5
NG - Nigeria 5
SV - El Salvador 5
AO - Angola 4
KW - Kuwait 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
AM - Armenia 3
BG - Bulgaria 3
GA - Gabon 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
MD - Moldavia 3
MN - Mongolia 3
PT - Portogallo 3
QA - Qatar 3
SY - Repubblica araba siriana 3
Totale 29.433
Salva come PNG Salva come JPEG
Città #
Singapore 1.610
Ashburn 1.371
Hong Kong 1.000
Ann Arbor 991
San Jose 975
Fairfield 569
Milan 559
Woodbridge 546
Ho Chi Minh City 484
Houston 471
Chandler 458
Dublin 435
New York 383
Hanoi 358
Toronto 354
Frankfurt am Main 321
Hefei 321
Council Bluffs 320
Santa Clara 299
Jacksonville 281
Wilmington 281
Los Angeles 276
Seattle 272
Beijing 262
Dallas 249
Dearborn 224
Chicago 212
The Dalles 192
Seoul 190
Cambridge 181
Rome 153
Princeton 147
Lauterbourg 123
Buffalo 112
Helsinki 111
Nanjing 107
Columbus 99
Jakarta 98
Shanghai 90
Boardman 87
São Paulo 85
Moscow 78
Guangzhou 67
Phoenix 59
Lawrence 55
Munich 55
Orem 55
Tokyo 54
Da Nang 52
Figino 51
Brooklyn 48
Hangzhou 47
Atlanta 46
Lachine 46
Baghdad 44
Chennai 42
Montreal 42
Haiphong 40
Altamura 37
London 37
San Diego 35
Nuremberg 33
Shenyang 33
Tashkent 32
Warsaw 31
Denver 30
Salt Lake City 29
Andover 27
Vienna 27
Ha Long 26
Johannesburg 26
Turin 26
Zhengzhou 26
Brasília 25
Can Tho 25
Changsha 25
Rio de Janeiro 25
Dhaka 24
Fremont 23
Lappeenranta 23
Nanchang 23
Padova 23
Philadelphia 23
Thái Nguyên 23
Hải Dương 22
Naples 22
Biên Hòa 21
Brussels 21
Lahore 21
Ottawa 21
Pune 21
Tianjin 21
Mexico City 20
Boston 19
Kunming 19
Manchester 19
San Francisco 19
Las Vegas 18
Quito 18
Washington 18
Totale 17.575
Salva come PNG Salva come JPEG
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 705
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties 568
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice 523
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTATIZATION IN CHOLANGIOCARCINOMA 442
Nephrosphere-Derived Cells are Induced to Multilineage Differentiation when Cultured on Human Decellularized Kidney Scaffolds 427
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 406
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 365
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 363
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 343
A ploidy increase promotes sensitivity of glioma stem cells to aurora kinases inhibition 340
The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts 339
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 330
TIMP1 Overexpression in Ovarian Cancer Spheroids: Implications for Prognosis, Resistance, and Metastatic Potential 327
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 320
Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression 312
Cholangiocyte biology as relevant to cystic liver diseases 311
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 306
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 302
Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma: Insights into Origins, Heterogeneity, Lymphangiogenesis, and Peritoneal Metastasis 295
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 287
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 285
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 281
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 280
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 277
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 276
Neural stem/progenitor cells from olfactory neuroepithelium collected by nasal brushing as a cell model reflecting molecular and cellular dysfunctions in schizophrenia 276
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 275
Animal models of cholestasis: An update on inflammatory cholangiopathies 275
Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1 270
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma 268
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 267
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 267
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 266
Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma 265
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 263
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 262
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 261
Pka-dependent p-ser-675-catenin phosphorylation increases cholangiocyte motility in a mouse model of fibropolycystic liver diseases 261
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTASIZATION IN CHOLANGIOCARCINOMA 259
The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored 257
Notch signaling and progenitor/ductular reaction in steatohepatitis 253
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 251
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids 247
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 247
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 246
The Deleterious Interplay Between Tumor Epithelia and Stroma in Cholangiocarcinoma 245
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases 243
The patient presenting with isolated hyperbilirubinemia 238
Nuclear expression of s100a4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization 237
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 235
Emerging concepts in biliary repair and fibrosis 234
Cholangiocarcinoma 233
Protein kinase a-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis 232
Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions 231
Cholangiocarcinoma 230
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 229
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH 227
Autocrine and paracrine mechanisms promoting chemoresistance in cholangiocarcinoma 220
Gender differences in repair mechanisms of chronic cholangiopathies with progressive fibrosis 218
Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis 217
Animal models for cystic fibrosis liver disease (CFLD) 215
Tumor microenvironment and immunology of cholangiocarcinoma 214
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression 212
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma 212
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease 211
Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation 211
Cxcl1 and cxcl10 secretion by fibrocistidefective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis 209
Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1−/− mouse model of congenital hepatic fibrosis 208
The evil relationship between liver fibrosis and cardiovascular disease in metabolic dysfunction-associated fatty liver disease (MAFLD): Looking for the culprit 208
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C 207
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM. 206
Steroid-loaded Avidin-Nucleic-Acid-Nano-Assemblies reduce hepatic fibrosis modulating Kupffer cells in primary biliary cholangitis 204
Role of angiogenesis and angiogenic factors for cholangiocyte growth 204
CXCL1 and CXCL10 secretion by fibrocistidefective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis 204
Fibroinflammatory liver injuries as preneoplastic condition in cholangiopathies 204
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance 202
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 200
Animal models of cholangiocarcinoma: What they teach us about the human disease 199
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer 197
Intrahepatic cholangiocarcinoma developing in patients with metabolic syndrome is characterized by Osteopontin overexpression in the tumor stroma 194
Cirrosi Biliare Primitiva 193
A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease 192
The healthy biliary tree: Cellular and immune biology 191
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 190
Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma 188
TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy 186
β-catenin and IL-1β dependent CXCL10 production drives progression of disease in a mouse model of Congenital Hepatic Fibrosis 185
Congenital cystic lesions of the biliary tree 183
Leukaemia Inhibitory Factor Protects Cholangiocarcinoma Cells From Cytotoxicity Via MCL-1 182
Molecular pathology analysis of sars-cov-2 in syncytiotrophoblast and hofbauer cells in placenta from a pregnant woman and fetus with covid-19 178
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases 178
Evidence of vertical transmission of SARS-CoV-2 and interstitial pneumonia in second-trimester twin stillbirth in asymptomatic woman. Case report and review of the literature 176
Evidence for biliary epithelial to mesenchymal transition in human cholangiocarcinoma 172
Anti-Inflammatory and Pro-Regenerative Effects of Hyaluronan-Chitlac Mixture in Human Dermal Fibroblasts: A Skin Ageing Perspective 171
The multitasking behavior of cholangiocyte in the reaction to liver damage 170
Colangite Sclerosante Primitiva 168
Oxidative Stress in Non-Autoimmune Liver Diseases 164
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA 163
Secretion of Vascular Endothelial Growth Factor-C by Cancer-Associated Fibroblasts (CAF) Is Stimulated by Platelet-Derived Growth Factor D (PDGF-D) and Promotes Lymphangiogenesis in Cholangiocarcinoma 162
Leukaemia inhibitory factor protects cholangiocytes from cytotoxicity in cholangiocarcinoma 162
Totale 25.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.082
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022509 0 0 0 45 27 50 31 37 36 67 85 131
2022/20231.670 167 501 166 161 118 240 26 89 100 12 45 45
2023/20242.104 76 70 68 131 351 467 355 103 223 19 39 202
2024/20254.715 275 532 334 175 388 221 229 203 366 706 504 782
2025/202612.277 1.605 1.103 781 1.188 1.158 598 1.523 534 888 1.116 831 952
2026/20273.092 527 802 1.496 267 0 0 0 0 0 0 0 0
Totale 30.078